Insider Trading & Ownership - AFEYAN NOUBAR

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for AFEYAN NOUBAR
Goto Prev, 0, 1, 2, 3
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-10-16
Purchase
2020-10-20
8:05 pm
Codiak BioSciences Inc. CDAK Flagship Ventures Fund V General Partner LLC
Flagship Ventures Fund V L.P.
Flagship V VentureLabs Rx Fund L.P.
AFEYAN NOUBAR
10% Owner
165,000 $15 $2,475,000 1,629,126
(Indirect)
View
2020-06-29
Purchase
2020-07-01
5:24 pm
Evelo Biosciences Inc. EVLO Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV L.P.
Flagship Ventures Fund IV-Rx L.P.
Flagship Ventures Opportunities Fund I General Partner LLC
Flagship Ventures Opportunities Fund I L.P.
AFEYAN NOUBAR
10% Owner
4,666,666 $3.75 $17,499,998 17,614,323
(Indirect)
View
2020-06-04
Purchase
2020-06-08
4:46 pm
Kaleido Biosciences Inc. KLDO Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV L.P.
Flagship Ventures Opportunities Fund I General Partner LLC
Flagship Ventures Opportunities Fund I L.P.
AFEYAN NOUBAR
10% Owner
2,000,000 $7.5 $15,000,000 14,835,960
(Indirect)
View
2020-05-21
Sale
2020-05-26
5:00 pm
Moderna Inc. MRNA Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV L.P.
Flagship Ventures Fund IV-Rx L.P.
AFEYAN NOUBAR
Director
10% Owner
1,000,000 $68.22 $68,219,276 19,274,952
(Indirect)
View
2020-05-18
Purchase
2020-05-20
5:15 pm
Axcella Health Inc. AXLA Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV L.P.
Flagship Ventures Fund IV-Rx L.P.
Flagship Ventures Opportunities Fund I General Partner LLC
Flagship Ventures Opportunities Fund I L.P.
AFEYAN NOUBAR
10% Owner
3,800,000 $4.75 $18,050,000 6,682,882
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2020-10-22
9:05 pm
N/A
N/A
Foghorn Therapeutics Inc. FHTX Flagship Ventures Fund V General Partner LLC
Flagship Ventures Opportunities Fund I General Partner LLC
Flagship Pioneering Special Opportunities Fund II General Partner LLC
Flagship Ventures Fund V L.P.
Flagship Ventures Opportunities Fund I L.P.
Flagship Pioneering Special Opportunities Fund II L.P.
Flagship Pioneering Inc.
AFEYAN NOUBAR
10% Owner
0 $0 12,524,120
(Indirect)
View
2020-10-16
Conversion
2020-10-20
8:05 pm
N/A
N/A
Codiak BioSciences Inc. CDAK Flagship Ventures Fund V General Partner LLC
Flagship Ventures Fund V L.P.
Flagship V VentureLabs Rx Fund L.P.
AFEYAN NOUBAR
10% Owner
15,631,605 $0 1,629,126
(Indirect)
View

Ownership
2020-10-13
9:20 pm
N/A
N/A
Codiak BioSciences Inc. CDAK Flagship Ventures Fund V General Partner LLC
Flagship VentureLabs V LLC
Flagship VentureLabs V Manager LLC
Flagship Pioneering Inc.
Flagship Ventures Fund V L.P.
Flagship V VentureLabs Rx Fund L.P.
AFEYAN NOUBAR
10% Owner
0 $0 2,443,243
(Indirect)
View
2020-08-17
Other
2020-08-19
8:15 pm
N/A
N/A
Moderna Inc. MRNA Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV L.P.
Flagship Ventures Fund IV-Rx L.P.
AFEYAN NOUBAR
Director
10% Owner
11,053,049 $0 24,619,111
(Indirect)
View
2020-05-21
Option Award
2020-05-26
7:24 pm
N/A
2030-05-20
Rubius Therapeutics Inc. RUBY AFEYAN NOUBAR
Director
10% Owner
25,000 $0 25,000
(Direct)
View
2020-05-11
Other
2020-05-13
6:12 pm
N/A
N/A
Moderna Inc. MRNA Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV L.P.
Flagship Ventures Fund IV-Rx L.P.
AFEYAN NOUBAR
Director
10% Owner
12,281,179 $0 25,135,365
(Indirect)
View
2020-04-29
Option Award
2020-04-30
9:19 pm
N/A
2030-04-29
Moderna Inc. MRNA AFEYAN NOUBAR
Director
10% Owner
18,270 $0 18,270
(Direct)
View
Goto Prev, 0, 1, 2, 3